CDCCityland Development Corporation

Cityland Development Corporation (PSE: CDC) last traded at ₱0.61, up 5.17% on the day, as of Sep 10, 2026. Prices on this page are delayed or end-of-day, not real time.

Cityland Development Corporation trades on the Philippine Stock Exchange under the ticker symbol CDC.

CDC is listed in the Property sector of the Philippine Stock Exchange, where it ranks #28 of 50 by market capitalization. Across the whole exchange it is #150 of 282, at ₱3.3B.

CDC has traded between ₱0.52 and ₱0.63 over the past 52 weeks. It is currently 3.2% below that high.

CDC's annualized volatility over the past year is 42.9%, which PSEye classifies as elevated against other PSE-listed stocks. Higher volatility means bigger day-to-day price swings in either direction, not necessarily a worse outcome. See the Analytics panel above for the full risk profile.

CDC trades at a price-to-earnings ratio of 4.7 and a price-to-book of 0.32, based on basic earnings per share from its latest annual filing (fiscal year ended Dec 31, 2025). Annual figures can be up to a year old, so this is not a trailing-twelve-month multiple.

PSEye doesn't label any stock overvalued or undervalued. CDC currently trades at a P/E of 4.7 and a P/B of 0.32, but whether that's cheap or expensive depends on the sector, growth prospects, and what comparable companies trade at, none of which a ratio alone can tell you. For comparison, Property peers with a computable ratio trade at a sector median P/E of 5.9 and a sector median P/B of 0.42 (32 peers). The Sector peers panel above lists 10 similarly-sized Property companies to compare against directly.

Yes. CDC has paid 1 cash dividend in the last twelve months, totalling ₱0.03 per share, a trailing yield of 5.34% at the current price. Cash dividends have a 10% final withholding tax deducted before they reach your account.

In its latest annual filing (fiscal year ended Dec 31, 2025), CDC's revenue grew 8.2% and net income fell 9.8% versus the prior fiscal year. That's one year-over-year comparison, not a multi-year trend, so check the Balance sheet & income statement panel above for the full figures before drawing a conclusion.

PSEye doesn't rate stocks as good or bad buys. What this page can tell you is factual: where CDC ranks by market cap (#150 of 282 on the exchange), its price history, valuation ratios, dividend record and recent company disclosures, all shown above. Whether that adds up to a good stock depends on your own criteria, and is worth researching beyond any single page, including this one.

PSEye is a data tracker, not a financial advisor, so it can't tell you whether to invest in CDC or any other stock. The price, valuation, dividend and disclosure data on this page is meant to help you do your own research. Consider your own goals, risk tolerance and time horizon, and consult a licensed financial advisor before making an investment decision. If you're weighing a fixed, regular investment instead of a single lump sum, PSEye's DCA calculator shows how that strategy would have performed historically.

To buy CDC shares, open an account with a PSE-accredited stockbroker (most Philippine banks and several standalone brokers offer online trading accounts), fund it, and place a buy order using the ticker symbol CDC. A completed trade typically settles two trading days later (T+2). PSEye doesn't process trades or recommend a specific broker.